2,4-Disubstituted quinazolines as amyloid-β aggregation inhibitors with dual cholinesterase inhibition and antioxidant properties: Development and structure-activity relationship (SAR) studies
Describes the design & synthesis of a novel class of quinazoline compound libraries. SAR studies demonstrate their anti-Aβ, anti-cholinesterase and antioxidant properties. They represent a new class of multi-targeting agents to treat Alzheimer’s disease.